Our overall goal is to develop a cell therapy product for the treatment of Parkinson's disease.  In the present proposal we will evaluate critical aspects of our manufacturing process to insure a consistent product that will ultimately be suitable for therapeutic use and improve the quality of life for patients afflicted by this disease.